Topic: Technology Licensing

Latest content

Chongqing is home to latest Chinese court asked to set global FRAND rate

The dispute between Oppo and Nokia has brought big-ticket global patent litigation to one of China’s biggest cities

10 November 2021

IP rights are an important part of the push for more renewables

Saturday Opinion: IP protection is a significant driver of clean energy production, but it’s not the only key factor

06 November 2021

InterDigital reveals financial impact of recent licensing deal with Xiaomi

An August litigation settlement with the Chinese giant means that 55% of the market is now taking licences from the firm

05 November 2021

A $650 million deal is the latest in a growing number of CRISPR IP transactions

Last week’s licensing agreement between Mammoth and Vertex shows how deal-making in the space is gathering momentum

05 November 2021

Mitsubishi Electric adds technology licensing to its monetisation push

Creation of an “open technology bank” for fee-based use comes as world’s third-biggest PCT filer also does more deals with NPEs

05 November 2021

Key takeaways from Merck’s landmark covid IP licensing deal with the Medicines Patent Pool

The agreement is the first granting non-exclusive and royalty free rights to sub-licensees of a covid therapeutic or vaccine

02 November 2021

Flexibility crucial to growing appeal of big money drug royalty transactions, says leading deal-maker

In the wake of the firm’s latest $250 million investment, Sagard Healthcare Royalty Partners’ Ali Alagheband gives the inside track on life sciences IP-backed revenue sales

01 November 2021

How next-generation patent pools can encourage adoption of new streaming tech

Saturday Opinion: Video codec licensing platforms must be inclusive, efficient and avoid the siren song of content distribution fees, argues Access Advance CEO Pete Moller

30 October 2021

Nokia Technologies boosts revenues and profits in strong Q3 patent licensing performance

Royalties grow on the back of new deals and renewals; company also shares new details on legal fight with Oppo, which does not appear to have significantly dimmed income outlook

29 October 2021

Talks over covid vaccine IP waiver appear increasingly futile

Saturday Opinion: The prospect of an international agreement on the proposed suspension of TRIPS now appears vanishingly small

23 October 2021

Get unlimited access to all IAM content